Home
Institutions
Filings
Issuers
About
All
Index / Passive
Hedge Fund
VC / PE / Holdco
Long-Term Concentrated
Concentrated Active
Quant / Systematic
Diversified Active
PHOENIX BIOTECH ACQUISITION
CUSIP: 71902K105
Class: CLASS A COM
Avantax Planning Partners, Inc.'s Holding History (CIK: 0001005441)
Note: Option positions (PUT/CALL) are excluded.
Q4 2024
Shares
2,585,151
Value ($000)
$155
Avg Close
—
Range
—
Q3 2024
Shares
1,361,130
Value ($000)
$127
Avg Close
—
Range
—
Q2 2024
Shares
80,000
Value ($000)
$24
Avg Close
—
Range
—
Period
Shares
Value ($000)
Average Close
Price Range
Q4 2024
2,585,151
$155
—
—
Q3 2024
1,361,130
$127
—
—
Q2 2024
80,000
$24
—
—